Walleye Trading’s LAVA Medtech Acquisition Corp. Class A Common Stock LVAC Stock Holding History

Walleye Trading’s Portfolio LVAC Stock Details LVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-54,000	Closed	-$563K	–	5442
2023 Q1	$563K	Hold	54,000	–	–	﹤0.01%	2697
2022 Q4	$550K	Hold	54,000	–	–	﹤0.01%	2731
2022 Q3	$542K	Hold	54,000	–	–	﹤0.01%	2839
2022 Q2	$538K	Hold	54,000	–	–	﹤0.01%	2841
2022 Q1	$539K	Buy	+54,000	New	+$536K	﹤0.01%	2836

Walleye Trading's LVAC Position: Q2 2023 in Review

Walleye Trading sold out of LAVA Medtech Acquisition Corp. Class A Common Stock (LVAC) in Q2 2023, closing a stake of 54,000 shares — an estimated $563K sold.

Walleye Trading first reported a position in LVAC in Q1 2022 and held it in 5 quarters. The position peaked at $563K in Q1 2023. 0 funds tracked by Wall St. Rank hold LVAC as of Q2 2023.

Walleye Trading reported no remaining LAVA Medtech Acquisition Corp. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
Walleye Trading sold 54,000 LAVA Medtech Acquisition Corp. Class A Common Stock shares in Q2 2023, an estimated $563K.
Walleye Trading first reported a position in LAVA Medtech Acquisition Corp. Class A Common Stock in Q1 2022 and held it in 5 quarters.
Walleye Trading's LAVA Medtech Acquisition Corp. Class A Common Stock position peaked at $563K in Q1 2023.
0 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Class A Common Stock as of Q2 2023.

Based on Walleye Trading's 13F filing for Q2 2023, filed 14 Aug 2023.